Updated bioinformatics pipeline improves accuracy and efficiency of VSG sequencing in trypanosoma brucei, indicating enhanced surveillance capabilities.
Trypanosoma brucei is an extracellular eukaryotic parasite that causes sleeping sickness in humans and Nagana, Surra and Dourine in livestock, game animals and horses. The parasite displays an extensive immune evasion mechanism, utilising the expression and ability to switch antigenically distinct variant surface glycoprotein (VSG) coats. VSG encoding genes account for ~10% of the T. brucei genome, and mosaic VSGs, assembled from distinct incomplete VSG gene copies, can be produced from this VSG library, generating an almost infinite VSG repertoire, which enables chronic infections. Each parasite expresses just one VSG at a time, but within a host, many VSGs can be expressed simultaneously. VSGSeq is an amplicon sequencing approach that enables surveillance of the population-wide diversity and abundance of expressed VSGs. vsgseq2 is an updated bioinformatics pipeline that enhances the reproducibility, accuracy, and efficiency of VSGseq analysis, utilising publicly available analytical tools.
No takes yet. Share an insight, caveat, or question.
Oldrieve et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: